Evidence map›Paper›PMID 33065268›Full record

ArticleAnnals of epidemiology2021

The role of epidemiology in informing United States childhood immunization policy and practice.

O Carter-Pokras, S Hutchins, J A Gaudino, S P Veeranki, P Lurie, T Weiser, M DeMarco, N F Khan, J F Cordero

Open access · greenAbstract read
In one paragraph

Article in Annals of epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

O Carter-PokrasDepartment of Epidemiology and Biostatistics, University of Maryland School of Public Health, College Park, MD. Electronic address: opokras@umd.edu.
S HutchinsCommunity Health and Preventive Medicine, Morehouse School of Medicine, NCPC, Atlanta, GA.
J A GaudinoGaudino Consulting and Departments of Epidemiology and Health Services and MCH Program, School of Public Health, University of Washington, Seattle, WA.
S P VeerankiPolicy & Economics, PRECISIONheor, Los Angeles, CA.
P LurieDivision of Infectious Disease Epidemiology, Pennsylvania Department of Health, Harrisburg, PA.
T WeiserPortland Area Indian Health Service, Northwest Portland Area Indian Health Board, Portland, OR.
M DeMarcoDepartment of Epidemiology and Biostatistics, University of Maryland School of Public Health, College Park, MD.
N F KhanDepartment of Epidemiology and Biostistics, University of Maryland School of Public Health, College Park, MD.
J F CorderoDepartment of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA.
University of Maryland, College Park · USIndian Health Service · USMorehouse School of Medicine · USPennsylvania Department of Health · USUniversity of Georgia · USUniversity of Washington · US

Funding

REDUCING HEALTH DISPARITIES IN MD ALONG THE NATIONAL CAPITAL BORDERU48DP001929 · DP · UNIV OF MARYLAND, COLLEGE PARK · PI BOEKELOO, BRADLEY O · 2009 to 2013
$1.9M
NCCDPHP CDC HHS U48 DP001929
6 · The paper itself

Abstract

One of the ten greatest public health achievements is childhood vaccination because of its impact on controlling and eliminating vaccine-preventable diseases (VPDs). Evidence-based immunization policies and practices are responsible for this success and are supported by epidemiology that has generated scientific evidence for informing policy and practice. The purpose of this report is to highlight the role of epidemiology in the development of immunization policy and successful intervention in public health practice that has resulted in a measurable public health impact: the control and elimination of VPDs in the United States. Examples in which epidemiology informed immunization policy were collected from a literature review and consultation with experts who have been working in this field for the past 30 years. Epidemiologic examples (e.g., thimerosal-containing vaccines and the alleged association between the measles, mumps, and rubella (MMR) vaccine and autism) are presented to describe challenges that epidemiologists have addressed. Finally, we describe ongoing challenges to the nation's ability to sustain high vaccination coverage, particularly with concerns about vaccine safety and effectiveness, increasing use of religious and philosophical belief exemptions to vaccination, and vaccine hesitancy. Learning from past and current experiences may help epidemiologists anticipate and address current and future challenges to respond to emerging infectious diseases, such as COVID-19, with new vaccines and enhance the public health impact of immunization programs for years to come.

Indexed as

COVID-19Measles-Mumps-Rubella VaccineHumansImmunizationImmunization ProgramsPolicySARS-CoV-2United StatesVaccinationMeasles-Mumps-Rubella VaccineChildrenEpidemiologyHealth disparitiesHealth equityHealth policyImmunizationVaccination

Identifiers

PMID33065268
PMCPMC7553935
OpenAlexW3093215728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.